Literature DB >> 34936041

An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosis.

Feng Zhang1, Xiaoqing Guo1, Yuanpeng Xia2, Ling Mao3.   

Abstract

Vascular smooth muscle cells (VSMCs) are involved in phenotypic switching in atherosclerosis. This switching is characterized by VSMC dedifferentiation, migration, and transdifferentiation into other cell types. VSMC phenotypic transitions have historically been considered bidirectional processes. Cells can adopt a physiological contraction phenotype or an alternative "synthetic" phenotype in response to injury. However, recent studies, including lineage tracing and single-cell sequencing studies, have shown that VSMCs downregulate contraction markers during atherosclerosis while adopting other phenotypes, including macrophage-like, foam cell, mesenchymal stem-like, myofibroblast-like, and osteochondral-like phenotypes. However, the molecular mechanism and processes regulating the switching of VSMCs at the onset of atherosclerosis are still unclear. This systematic review aims to review the critical outstanding challenges and issues that need further investigation and summarize the current knowledge in this field.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Atherosclerosis; Phenotypic switching; VSMCs

Mesh:

Year:  2021        PMID: 34936041     DOI: 10.1007/s00018-021-04079-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  180 in total

1.  Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis.

Authors:  Sima Allahverdian; Ali Cyrus Chehroudi; Bruce M McManus; Thomas Abraham; Gordon A Francis
Journal:  Circulation       Date:  2014-01-30       Impact factor: 29.690

2.  Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype.

Authors:  Yuliya Vengrenyuk; Hitoo Nishi; Xiaochun Long; Mireille Ouimet; Nazir Savji; Fernando O Martinez; Courtney P Cassella; Kathryn J Moore; Stephen A Ramsey; Joseph M Miano; Edward A Fisher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-01-08       Impact factor: 8.311

3.  Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis.

Authors:  Clément Cochain; Ehsan Vafadarnejad; Panagiota Arampatzi; Jaroslav Pelisek; Holger Winkels; Klaus Ley; Dennis Wolf; Antoine-Emmanuel Saliba; Alma Zernecke
Journal:  Circ Res       Date:  2018-03-15       Impact factor: 17.367

Review 4.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease.

Authors:  Gary K Owens; Meena S Kumar; Brian R Wamhoff
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

5.  Single-Cell Genomics Reveals a Novel Cell State During Smooth Muscle Cell Phenotypic Switching and Potential Therapeutic Targets for Atherosclerosis in Mouse and Human.

Authors:  Huize Pan; Chenyi Xue; Benjamin J Auerbach; Mingyao Li; Muredach P Reilly; Jiaxin Fan; Alexander C Bashore; Jian Cui; Dina Y Yang; Sarah B Trignano; Wen Liu; Jianting Shi; Chinyere O Ihuegbu; Erin C Bush; Jeremy Worley; Lukas Vlahos; Pasquale Laise; Robert A Solomon; Edward S Connolly; Andrea Califano; Peter A Sims; Hanrui Zhang
Journal:  Circulation       Date:  2020-09-23       Impact factor: 29.690

6.  Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis.

Authors:  Susanne Feil; Birgit Fehrenbacher; Robert Lukowski; Frank Essmann; Klaus Schulze-Osthoff; Martin Schaller; Robert Feil
Journal:  Circ Res       Date:  2014-07-28       Impact factor: 17.367

7.  Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading.

Authors:  James X Rong; Mark Shapiro; Eugene Trogan; Edward A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-27       Impact factor: 11.205

8.  KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis.

Authors:  Laura S Shankman; Delphine Gomez; Olga A Cherepanova; Morgan Salmon; Gabriel F Alencar; Ryan M Haskins; Pamela Swiatlowska; Alexandra A C Newman; Elizabeth S Greene; Adam C Straub; Brant Isakson; Gwendalyn J Randolph; Gary K Owens
Journal:  Nat Med       Date:  2015-05-18       Impact factor: 53.440

9.  Mouse strains to study cold-inducible beige progenitors and beige adipocyte formation and function.

Authors:  Daniel C Berry; Yuwei Jiang; Jonathan M Graff
Journal:  Nat Commun       Date:  2016-01-05       Impact factor: 14.919

10.  Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis.

Authors:  Juyong B Kim; Thomas Quertermous; Robert C Wirka; Dhananjay Wagh; David T Paik; Milos Pjanic; Trieu Nguyen; Clint L Miller; Ramen Kundu; Manabu Nagao; John Coller; Tiffany K Koyano; Robyn Fong; Y Joseph Woo; Boxiang Liu; Stephen B Montgomery; Joseph C Wu; Kuixi Zhu; Rui Chang; Melissa Alamprese; Michelle D Tallquist
Journal:  Nat Med       Date:  2019-07-29       Impact factor: 53.440

View more
  3 in total

1.  Ginsenoside Rh1 Inhibits Angiotensin II-Induced Vascular Smooth Muscle Cell Migration and Proliferation through Suppression of the ROS-Mediated ERK1/2/p90RSK/KLF4 Signaling Pathway.

Authors:  Diem Thi Ngoc Huynh; Yujin Jin; Dung Van Nguyen; Chang-Seon Myung; Kyung-Sun Heo
Journal:  Antioxidants (Basel)       Date:  2022-03-27

Review 2.  Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis.

Authors:  Lin Mao; Ruili Yin; Longyan Yang; Dong Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-31       Impact factor: 6.055

Review 3.  Vascular homeostasis in atherosclerosis: A holistic overview.

Authors:  Suowen Xu; Qing Rex Lyu; Iqra Ilyas; Xiao-Yu Tian; Jianping Weng
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.